Chemical Bio Research

Chemical Biology Research (CBR) is a specialized biotechnology company focused on the intersection of chemistry and biology to accelerate drug discovery. The company utilizes a proprietary platform that combines high-throughput screening with advanced chemical proteomics to identify novel small molecule modulators for challenging biological targets. CBR provides both internal pipeline development and contract research services to pharmaceutical partners, specializing in the characterization of protein-ligand interactions. Their expertise spans across multiple therapeutic areas, including oncology and metabolic disorders, with a focus on early-stage lead optimization. By leveraging synthetic chemistry and functional genomics, CBR aims to bridge the gap between target identification and clinical candidate selection.